Financing Outlook 1H 2024:
Show Me the Money
Healthcare venture funding is recovering in 2024, with increased investments across Healthtech, Med Device, Biopharma, and Diagnostics. Investor confidence is rising, though challenges like weak exits and valuation concerns remain. Med Device funding surged, and M&A activity gained momentum. While uncertainties persist, experts foresee continued growth, marking a cautiously optimistic outlook for the sector.
Visit us https://www.lifesciencemarketr....esearch.com/insights
お気に入り
コメント
シェア
